Anna Berkenblit - 31 Dec 2021 Form 4 Insider Report for ImmunoGen, Inc.

Role
SVP & Chief Medical Officer
Signature
/s/ Renee Lentini, attorney in fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
+$9,862
Form type
4
Filing time
04 Jan 2022, 15:08:59 UTC
Previous filing
16 Aug 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $9,862 +1,761 +1.7% $5.60 107,162 31 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2021 through December 31, 2021.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2021.